WoundMetrics Inc.
WoundMetrics Inc. is a technology company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
WoundMetrics Inc. is a technology company.
WoundMatrix Inc. (also referenced as WoundMetrics in some investor contexts) is a healthcare technology company specializing in cloud-based wound assessment, tracking, and documentation software.[1][2] It develops mobile and web-based solutions that enable clinicians to capture real-time wound images, perform precise measurements, and generate outcome reports, serving inpatient, outpatient, home care, telemedicine, and clinical research settings to improve patient outcomes and reduce costs.[1][2][4]
The platform addresses key challenges in wound care by standardizing documentation, minimizing measurement variability (validated by a Johns Hopkins study), and ensuring HIPAA and 21CFR11 compliance.[1][2] Targeted at healthcare providers, payers, governments, and researchers, it drives better care quality, regulatory adherence, and efficiency in value-based care models.[1][2]
WoundMatrix Inc. was founded in 2000 (with key incorporation in 2001) by Sean M. Geary (CEO) and Paul A. Geary III (Senior VP of Sales), both bringing expertise in software development and sales for the wound and skin care market.[2] Sean, a University of Notre Dame graduate with a Communications degree, has overseen product strategy, partnerships, and expansion into payers, private sectors, government, education, and clinical research.[2]
The idea emerged from a need for accurate digital wound measurement and documentation, evolving from early software to pivotal innovations like WoundMatrix Web—the first mobile and web-based solution.[2] Early traction came through national and international adoption, with ongoing growth via integrations (e.g., UK’s Rio EPR system) and focus on evidence-based wound therapy.[1][2]
WoundMatrix rides the wave of digital health and telewoundcare, capitalizing on mobile AI, cloud interoperability, and value-based care trends amid rising chronic wound prevalence (e.g., diabetes-related).[1][2][4] Timing aligns with post-pandemic telehealth acceleration and regulatory pushes for precise, data-driven outcomes, where traditional manual methods fall short in accuracy and efficiency.[1]
Market forces like EHR integrations, remote monitoring demands, and clinical trial needs favor its model, influencing the ecosystem by standardizing wound data for research discoveries and better global patient care—positioning it against competitors like eKare in a fragmented but growing medtech space.[1][2][3]
WoundMatrix is poised for expansion through AI-enhanced analytics, deeper EHR APIs, and international scaling, leveraging its 25-year track record to capture more of the telehealth wound management market.[1][2] Trends like predictive wound healing models and regulatory emphasis on outcomes will propel growth, potentially via acquisitions or pharma partnerships.
Its influence may evolve from documentation leader to full AI-driven platform, amplifying impact on evidence-based medicine and cost savings—reinforcing its role as a foundational player in transforming wound care from reactive to proactive.